Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

OCU 100

Next Previous
Drug Profile

OCU 100

Alternative Names: LEDGF-1-326; OCU-100; recombinant LEDGF1-326 - Ocugen

Latest Information Update: 29 Mar 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Colorado at Anschutz Medical Campus
  • Developer Ocugen
  • Class Biological proteins; Eye disorder therapies; Peptide fragments
  • Mechanism of Action Signal transducing adaptor protein modulators; Transcription factor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Retinitis pigmentosa
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Retinitis pigmentosa

Most Recent Events

  • 17 Mar 2022 Discontinued - Preclinical for Retinitis pigmentosa in USA (unspecified route) prior to March 2022 (Ocugen pipeline, March 2022)
  • 28 Aug 2020 No recent reports of development identified for preclinical development in Retinitis-pigmentosa in USA
  • 01 Jan 2019 OCU 100 receives Orphan Drug status for Retinitis pigmentosa in European Union before January 2019 (Ocugen pipeline, January 2019)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top